JO1785B1 - Therapeutic agent - Google Patents
Therapeutic agentInfo
- Publication number
- JO1785B1 JO1785B1 JO19941785A JOP19941785A JO1785B1 JO 1785 B1 JO1785 B1 JO 1785B1 JO 19941785 A JO19941785 A JO 19941785A JO P19941785 A JOP19941785 A JO P19941785A JO 1785 B1 JO1785 B1 JO 1785B1
- Authority
- JO
- Jordan
- Prior art keywords
- optionally substituted
- alkyl
- phenyl
- hydroxy
- integer
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000019022 Mood disease Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- -1 sulphamoyl Chemical group 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof in which m is an integer from 1 to 3; n is an integer from 2 to 6; R1 is phenyl optionally substituted by one or more substituents selected from halo, hydroxy, alkoxy, alkanoyl, alkyl, halogenated alkyl, alkylthio, alkylsulphinyl, alkylsulphonyl, cyano, nitro, optionally substituted amino, optionally substituted sulphamoyl, optionally substituted carbamoyl or phenyl, or R1 is naphthyl; R2 is H, alkyl or phenyl; R3 is H, alkyl, alkenyl or alkoxyalkyl; R4 is H or hydroxy; and R5 is H or together with R4 represents a bond; have utility in the treatment of obesity and affective disorders such as depression and anxiety.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JO19941785A JO1785B1 (en) | 1994-04-21 | 1994-04-21 | Therapeutic agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JO19941785A JO1785B1 (en) | 1994-04-21 | 1994-04-21 | Therapeutic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO1785B1 true JO1785B1 (en) | 1994-12-25 |
Family
ID=48142163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JO19941785A JO1785B1 (en) | 1994-04-21 | 1994-04-21 | Therapeutic agent |
Country Status (1)
| Country | Link |
|---|---|
| JO (1) | JO1785B1 (en) |
-
1994
- 1994-04-21 JO JO19941785A patent/JO1785B1/en active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20022676B (en) | 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors | |
| GB9524157D0 (en) | Therapeutic agents | |
| NZ333706A (en) | Benzenesulfone derivatives and medicaments | |
| NZ315400A (en) | Pyridazin-3-one derivatives, their use, and intermediates for their production | |
| AP2002002637A0 (en) | Novel piperazine | |
| NZ332762A (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| UA66825C2 (en) | Azapolycyclic compounds condensed with aryl | |
| NO951797L (en) | Therapeutic agents | |
| NZ334976A (en) | Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses | |
| BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
| ZA941963B (en) | Substituted (arylalkoxybenzyl)aminopropanamide derivatives and process for their preparation | |
| MX9800532A (en) | Synergistic herbicidal composition and method of use thereof. | |
| ZA836849B (en) | Therapeutic agents | |
| WO2001000185A3 (en) | 1,4-denzothiazepines to treat obesity related disorders | |
| MY131690A (en) | 6-[triazolyl[3-(trifluoromethyl) phenyl]methyl]-2- quinolinones and -quinolinethiones | |
| HU9501317D0 (en) | Aza-spiro-alkanes derivatives as therapeutic agents | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| DK1049672T3 (en) | Azetidine carboxamide derivatives for the treatment of CNS disorders | |
| TW429147B (en) | Pharmaceutical composition for the treatment of CNS disorders | |
| AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
| AP2000002009A0 (en) | Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity. | |
| DK1049670T3 (en) | Azetidine carboxamide derivatives for the treatment of CNS disorders | |
| AU2001251662A1 (en) | Benzoxazines for use in the treatment of parkinson's disease | |
| MY130671A (en) | Substituted benzopyran derivatives for the treatment of inflammation | |
| JO1728B1 (en) | Therapeutic agent |